Biomark Diagnostics Inc. (BMKDF)
OTCMKTS · Delayed Price · Currency is USD
0.2540
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT

Biomark Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
251618111324
Upgrade
Market Cap Growth
63.08%-15.13%60.82%-9.22%-48.38%157.32%
Upgrade
Enterprise Value
241719131425
Upgrade
Last Close Price
0.250.180.220.140.170.33
Upgrade
PS Ratio
221.49145.04152.12100.50356.91-
Upgrade
PB Ratio
25.7712.85-40.73-13.42-24.67-386.98
Upgrade
P/TBV Ratio
25.7712.85----
Upgrade
EV/Sales Ratio
212.62154.52161.35110.73393.16-
Upgrade
Debt / Equity Ratio
0.770.64-2.54-1.44-3.09-12.70
Upgrade
Asset Turnover
0.090.070.180.140.04-
Upgrade
Quick Ratio
1.852.140.160.060.310.98
Upgrade
Current Ratio
1.852.140.160.080.331.00
Upgrade
Return on Equity (ROE)
-504.79%-340.70%----
Upgrade
Return on Assets (ROA)
-62.79%-60.59%-117.29%-104.38%-66.20%-80.77%
Upgrade
Return on Capital (ROIC)
-71.73%-67.44%-148.56%-125.52%-71.12%-259.30%
Upgrade
Earnings Yield
-5.01%-8.62%-5.75%-11.94%-9.27%-3.57%
Upgrade
FCF Yield
-3.09%-4.90%-3.98%-5.96%-8.06%-2.64%
Upgrade
Buyback Yield / Dilution
-8.42%-6.67%-2.97%-6.22%-6.31%-2.82%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.